News | April 11, 2024
Asahi Kasei Bioprocess and Axolabs partner to accelerate oligonucleotide therapeutics development
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes
The board gave in-principle approval for expansion of company's footprint in Lucknow
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services
Increased capability to produce medicines for challenging diseases including cancer
The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months
The market capitalization of the company stood at Rs. 7,000 crore +
Marking a significant milestone in its commitment to holistic wellness
Sets price band at ?695 to ?735 per Equity Share
Subscribe To Our Newsletter & Stay Updated
